U.S. Construction Stock News

NYSE:PRMB
NYSE:PRMBBeverage

Primo Brands Q1 Profitability Return Challenges Bearish Narratives On One Off Loss

Primo Brands (PRMB) opened 2026 with Q1 revenue of US$1.6 billion and basic EPS of US$0.08, alongside net income from ongoing operations of US$27.3 million. This sets the tone for how the year is starting to shape up. The company has seen quarterly revenue move from US$1.31 billion in Q3 2024 to between US$1.55 billion and US$1.77 billion through 2025. Over the same period, basic EPS ranged from a loss of US$0.07 to a high of US$0.24, providing a clear view of how profits have shifted as...
NasdaqGS:CG
NasdaqGS:CGCapital Markets

Carlyle Group Expands Into AI Healthcare RCM With Undervalued Shares

Carlyle Group (NasdaqGS:CG) has acquired majority stakes in Knack RCM and EqualizeRCM. The deals are part of a plan to build a new healthcare revenue cycle management platform. The platform is expected to use artificial intelligence tools across its operations. The move marks a shift toward healthcare services and recurring revenue opportunities. Carlyle Group is widely known for its global private equity and alternative asset management operations, and this step pulls the firm deeper into...
NasdaqGM:MKTW
NasdaqGM:MKTWCapital Markets

MarketWise (MKTW) Q1 Loss After Four Profitable Quarters Challenges Profitability Narratives

MarketWise (MKTW) opened 2026 with Q1 revenue of US$77.0 million and a basic EPS loss of US$0.23, compared with Q1 2025 revenue of US$83.5 million and EPS of US$0.43. This set a clear reset in the earnings run rate. Over the past year, the company has seen total revenue across reported quarters move from US$97.5 million in Q4 2024 to a range between about US$80 million and US$83 million through 2025. Quarterly EPS shifted from US$1.07 in Q4 2024 to positive figures across 2025 before slipping...
NasdaqGM:RAPP
NasdaqGM:RAPPPharmaceuticals

Rapport Therapeutics (RAPP) First Revenue Of US$20m Tests Bullish Growth Narratives

Rapport Therapeutics (RAPP) opened Q1 2026 with revenue of US$20 million, a basic EPS loss of US$0.42, and a net income loss of US$19.86 million, providing a clear snapshot of a company still in investment mode. Over the past year, the company has seen quarterly revenue move from US$0 to US$20 million, while quarterly basic EPS loss shifted between US$0.57 and US$0.75 before landing at US$0.42 in the latest quarter. This gives investors a clearer view of how top-line and per-share losses are...
NYSE:EPAM
NYSE:EPAMIT

EPAM Systems Q1 2026 Margin Compression Tests Bullish AI Growth Narrative

EPAM Systems (EPAM) opened Q1 2026 with revenue of about US$1.4 billion and basic EPS of US$1.53, while over the trailing twelve months it recorded revenue of roughly US$5.6 billion and basic EPS of US$7.01, setting a clear snapshot of its recent scale and earnings power. Over the past reported periods, revenue has moved from US$1,301.7 million in Q1 2025 to US$1,400.1 million in Q1 2026, with quarterly basic EPS ranging between US$1.29 and US$1.99 during that stretch. This gives investors a...
NasdaqCM:AKBA
NasdaqCM:AKBABiotechs

Akebia Therapeutics (AKBA) Losses Narrow To US$9.1 Million Challenging Bearish Profitability Narratives

Akebia Therapeutics (AKBA) opened Q1 2026 with total revenue of US$53.5 million and a basic EPS loss of US$0.03, alongside a quarterly net loss of US$9.1 million. On a trailing twelve month basis, revenue was US$232.4 million with a net loss of US$20.5 million and basic EPS of US$0.08. Over the last five reported quarters, the company has seen quarterly revenue range between US$46.5 million and US$62.5 million, with basic EPS moving from a profit of US$0.03 in Q1 2025 to losses such as...
NYSE:NRG
NYSE:NRGElectric Utilities

NRG Energy Q1 EPS Drop To US$0.52 Tests Bullish Margin Expansion Narratives

NRG Energy (NRG) has laid out a busy start to 2026, with Q1 revenue of about US$10.3b and net income of US$108m translating into EPS of US$0.52, alongside trailing twelve month revenue of roughly US$32.4b and EPS of US$0.87. The company has seen quarterly revenue move from US$6.8b in Q4 2024 to US$8.6b in Q1 2025 and then to US$10.3b in Q1 2026, while quarterly EPS shifted from US$3.09 to US$3.70 and then to US$0.52 over the same stretch, setting a mixed backdrop for the latest print. With...
NasdaqGS:GDRX
NasdaqGS:GDRXHealthcare Services

GoodRx Holdings (GDRX) Thin Q1 Profit Margins Test Bullish Earnings Growth Narratives

GoodRx Holdings (GDRX) has posted Q1 2026 revenue of US$194.0 million with basic EPS of about US$0.00, alongside trailing twelve month revenue of US$787.9 million and basic EPS of US$0.06. This gives investors a clear read on both the latest quarter and the broader run rate. Over the past year, the company has seen quarterly revenue move between US$194.0 million and US$203.1 million, while basic EPS has ranged from roughly US$0.00 to US$0.04, so the Q1 print slots into a period where earnings...
NasdaqGM:LNTH
NasdaqGM:LNTHMedical Equipment

Lantheus Holdings (LNTH) One Off Gain Lifts Margins And Tests Earnings Quality Narratives

Lantheus Holdings (LNTH) opened 2026 with Q1 revenue of US$377.3 million and basic EPS of US$1.83, alongside net income of US$118.4 million, setting a clear marker for the latest reporting period. The company has seen quarterly revenue move from US$372.8 million in Q1 2025 to US$377.3 million in Q1 2026, while basic EPS shifted from US$1.06 to US$1.83 over the same stretch. This gives investors a clear view of how the top and bottom lines are tracking. With trailing net margin sitting above...
NYSE:ARW
NYSE:ARWElectronic

Arrow Electronics (ARW) Margin Rebound And 84.7% Earnings Gain Test Bearish Narratives

Arrow Electronics (ARW) opened Q1 2026 with total revenue of about US$9.5b and basic EPS of US$4.58, setting a clear marker for how its core distribution and solutions business is performing as the year gets underway. Over recent quarters the company has seen revenue move from roughly US$7.3b in Q4 2024 to US$6.8b in Q1 2025 and then up to US$9.5b in Q1 2026, while quarterly basic EPS shifted from US$1.88 to US$1.53 and then to US$4.58, giving investors a concrete read on how earnings are...
NYSE:CRL
NYSE:CRLLife Sciences

Charles River Laboratories (CRL) Q1 Loss Of US$14.8m Tests Profitability Recovery Narrative

Charles River Laboratories International (CRL) opened 2026 with Q1 revenue of US$995.8 million and a basic EPS loss of US$0.30, alongside net income excluding extra items of a US$14.8 million loss, with the stock trading around US$181.68. The company has seen quarterly revenue move from US$984.2 million in Q1 2025 to just over US$1.0 billion across several recent periods, while basic EPS has swung between a profit of about US$1.11 and a much larger loss of about US$5.62. This has left margins...
NYSE:WTS
NYSE:WTSMachinery

Watts Water Technologies Q1 EPS Strength Tests Bearish Revenue Concerns

Watts Water Technologies (WTS) opened 2026 with Q1 revenue of US$677.3 million and basic EPS of US$2.97, while the trailing twelve months show total revenue of US$2.56 billion and basic EPS of US$10.94, supported by net income of US$366.4 million. The company has seen quarterly revenue move from US$558 million and EPS of US$2.21 in Q1 2025 to US$677.3 million and EPS of US$2.97 in Q1 2026. The trailing net profit margin is 14.3%, compared with 13.1% a year earlier, highlighting an earnings...
NYSE:CSV
NYSE:CSVConsumer Services

Carriage Services (CSV) Q1 2026 Earnings Highlight Margin Strength Against Flat Revenue Narrative

Carriage Services (CSV) has opened 2026 with Q1 revenue of US$106.1 million and basic EPS of US$0.85, alongside trailing 12 month revenue of US$416.5 million and basic EPS of US$2.81 that sit against a 56.3% year over year earnings growth figure and a 12.2% net margin. Over recent quarters, revenue has moved between US$97.7 million in Q4 2024 and US$107.1 million in Q1 2025, while quarterly basic EPS has ranged from US$0.43 to US$1.35. This gives investors a clearer view of how the current...
NasdaqGS:PRVA
NasdaqGS:PRVAHealthcare

Privia Health Group Q1 Profit Squeeze Tests Bullish High P E Narrative

Privia Health Group (PRVA) opened 2026 with Q1 revenue of US$603.8 million and net income of US$3.1 million, translating to basic EPS of US$0.02. Trailing twelve month EPS stood at US$0.18 on revenue of US$2.2 billion. Over the past year, the company has seen revenue move from US$1.7 billion in Q4 2024 to US$2.2 billion in Q1 2026 and EPS shift from US$0.12 to US$0.18. This gives investors a clearer view of how recent quarters are feeding into the rolling totals. With margins edging higher...
NYSE:BKSY
NYSE:BKSYProfessional Services

BlackSky Technology (BKSY) Posts Heavy Q1 Losses That Test High‑Growth Bullish Narratives

BlackSky Technology (BKSY) opened 2026 with Q1 revenue of about US$20.8 million and a loss per share of roughly US$0.82, as net income excluding extra items came in at a loss of US$29.7 million against a share price of US$32.24. Over recent quarters, the company has seen revenue move between US$19.6 million and US$35.2 million while EPS ranged from a loss of about US$0.02 to US$1.27. This sets a mixed backdrop for investors who are focused on how quickly margins might eventually firm up. See...
NYSE:SMR
NYSE:SMRElectrical

NuScale Power Partnerships Target Industrial Heat And European SMR Growth

NuScale Power (NYSE:SMR) announced a collaborative R&D program with Ebara Elliott Energy to develop high temperature steam compressors for industrial customers, including petrochemical process heat. The company also expanded its partnership with Framatome to fabricate fuel assemblies for NuScale’s European small modular reactor customers. These agreements aim to support non electric applications and strengthen NuScale’s global supply chain as policy attention and data center energy needs...
NYSE:SEG
NYSE:SEGReal Estate

Seaport Entertainment Group (SEG) Q1 Loss Of US$44.1 Million Deepens Bearish Narratives

Seaport Entertainment Group Q1 2026 earnings snapshot Seaport Entertainment Group (SEG) opened 2026 with Q1 revenue of US$12.7 million and a basic EPS loss of US$3.47, with net income excluding extra items at a loss of US$44.1 million. This sets a cautious tone around profitability at a current share price of US$22.24. The company reported that quarterly revenue moved from US$16.2 million in Q1 2025 to US$12.7 million in Q1 2026, while basic EPS shifted from a loss of US$2.51 to a loss of...
NYSE:U
NYSE:USoftware

Unity Software (U) Q1 Loss Surge Tests Bullish Profitability Narratives

Unity Software (U) opened Q1 2026 with revenue of US$508.2 million and a basic EPS loss of US$0.80, compared with US$435.0 million of revenue and a basic EPS loss of US$0.19 in Q1 2025, while trailing 12 month revenue sat at about US$1.9 billion and EPS at a loss of US$1.58. Over the past year, quarterly revenue has ranged from US$435.0 million to US$508.2 million and quarterly EPS losses have moved between US$0.19 and US$0.80, giving investors a clear view of the trade off between scale and...
NYSE:ABT
NYSE:ABTMedical Equipment

What Abbott Laboratories (ABT)'s New AI Cardiac Imaging, Trial Data and Share Plan Mean For Shareholders

In late April 2026, Abbott received FDA clearance for its next-generation Ultreon 3.0 AI-powered OCT imaging software, while also expanding its board to thirteen directors and adding Kevin Conroy and Paola Gonzalez following its Annual Meeting of Shareholders. Abbott simultaneously advanced its cardiovascular technology pipeline with new late-breaking trial data on pulsed field ablation and conduction system pacing devices, and registered a US$14.13 billion employee share offering shelf to...
NYSE:UGI
NYSE:UGIGas Utilities

UGI (UGI) Q2 2026 Margin Improvement Challenges Long‑Running Earnings Skepticism

UGI (UGI) has just posted Q2 2026 results that put the spotlight firmly on its income statement, with revenue of about US$2.7b and basic EPS of US$2.42, while trailing twelve month revenue sits at US$7.4b and EPS at US$2.98. Over the past few quarters, revenue has ranged from US$1.2b in Q4 2024 to around US$2.7b in Q2 2026, with quarterly EPS moving from a loss of US$1.27 in Q4 2024 to a gain of US$2.42 most recently, and trailing twelve month net income reaching US$641m. For investors, the...
NasdaqGS:IREN
NasdaqGS:IRENSoftware

IREN Rethinks Bitcoin Roots With Global AI Cloud And NVIDIA Backing

IREN (NasdaqGS:IREN) has agreed a partnership with NVIDIA to deploy up to 5GW of AI infrastructure globally, with NVIDIA holding a right to invest up to $2.1b. The company announced the $625m acquisition of cloud software provider Mirantis to support delivery of integrated AI cloud solutions. IREN also acquired Spain based Nostrum Group, adding nearly 500MW of grid connected capacity and marking its entry into Europe. For investors tracking NasdaqGS:IREN, the company is shifting from a pure...
NasdaqGS:PODD
NasdaqGS:PODDMedical Equipment

Insulet (PODD) Margin Compression Challenges Bullish Growth Narratives After Q1 2026 Results

Insulet (PODD) opened 2026 with Q1 revenue of US$761.7 million and basic EPS of US$1.30, while trailing twelve month revenue sat at about US$2.9 billion with basic EPS of US$4.31. This gives investors a clear view of both the quarterly print and the recent run rate. Over the last six reported quarters, revenue has moved from US$569 million in Q1 2025 to US$761.7 million in Q1 2026, with quarterly basic EPS ranging between US$0.32 and US$1.44 over that stretch. With trailing net profit margin...
NYSE:OEC
NYSE:OECChemicals

Orion (OEC) Trailing Losses Deepen And Test Bullish Margin Expansion Narratives

Q1 2026 earnings snapshot Orion (OEC) opened 2026 with Q1 revenue of US$459.5 million and a basic EPS loss of US$0.18, alongside a trailing 12 month EPS loss of US$1.59 on revenue of about US$1.8 billion, setting a cautious tone around profitability. Over recent quarters the company has seen revenue move between US$411.7 million and US$477.7 million, while quarterly EPS has ranged from a profit of about US$0.30 to a loss of US$1.20, giving investors a wide band of earnings outcomes to weigh...
NasdaqGS:MTLS
NasdaqGS:MTLSSoftware

Materialise (NasdaqGS:MTLS) Margin Uptick To 3.8% Tests Bullish Profitability Narratives

Materialise (NasdaqGS:MTLS) opened 2026 with Q1 revenue of €66.3 million and basic EPS of €0.03. This helps set the tone for how the year is starting to shape up after a busy 2025. The company has seen quarterly revenue move between €64.8 million and €70.2 million over the past year, while basic EPS ranged from a small loss of €0.01 in Q1 2025 to €0.11 in Q4 2025. This gives investors a clearer view of how profits track against a relatively steady top line. With trailing twelve month net...